Literature DB >> 21444803

Discovery and molecular characterization of a Bcl-2-regulated cell death pathway in schistosomes.

Erinna F Lee1, Oliver B Clarke, Marco Evangelista, Zhiping Feng, Terence P Speed, Elissaveta B Tchoubrieva, Andreas Strasser, Bernd H Kalinna, Peter M Colman, W Douglas Fairlie.   

Abstract

Schistosomiasis is an infectious disease caused by parasites of the phylum platyhelminthe. Here, we describe the identification and characterization of a Bcl-2-regulated apoptosis pathway in Schistosoma japonicum and S. mansoni. Genomic, biochemical, and cell-based mechanistic studies provide evidence for a tripartite pathway, similar to that in humans including BH3-only proteins that are inhibited by prosurvival Bcl-2-like molecules, and Bax/Bak-like proteins that facilitate mitochondrial outer-membrane permeabilization. Because Bcl-2 proteins have been successfully targeted with "BH3 mimetic" drugs, particularly in the treatment of cancer, we investigated whether schistosome apoptosis pathways could provide targets for future antischistosomal drug discovery efforts. Accordingly, we showed that a schistosome prosurvival protein, sjA, binds ABT-737, a well-characterized BH3 mimetic. A crystal structure of sjA bound to a BH3 peptide provides direct evidence for the feasibility of developing BH3 mimetics to target Bcl-2 prosurvival proteins in schistosomes, suggesting an alternative application for this class of drugs beyond cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21444803      PMCID: PMC3084110          DOI: 10.1073/pnas.1100652108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

Review 1.  BH3-Only proteins-essential initiators of apoptotic cell death.

Authors:  D C Huang; A Strasser
Journal:  Cell       Date:  2000-12-08       Impact factor: 41.582

2.  Sponge Bcl-2 homologous protein (BHP2-GC) confers distinct stress resistance to human HEK-293 cells.

Authors:  M Wiens; B Diehl-Seifert; W E Müller
Journal:  Cell Death Differ       Date:  2001-09       Impact factor: 15.828

3.  Molecular evolution of apoptotic pathways: cloning of key domains from sponges (Bcl-2 homology domains and death domains) and their phylogenetic relationships.

Authors:  M Wiens; A Krasko; C I Müller; W E Müller
Journal:  J Mol Evol       Date:  2000-06       Impact factor: 2.395

4.  Basic local alignment search tool.

Authors:  S F Altschul; W Gish; W Miller; E W Myers; D J Lipman
Journal:  J Mol Biol       Date:  1990-10-05       Impact factor: 5.469

5.  BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak.

Authors:  W X Zong; T Lindsten; A J Ross; G R MacGregor; C B Thompson
Journal:  Genes Dev       Date:  2001-06-15       Impact factor: 11.361

6.  Hid, Rpr and Grim negatively regulate DIAP1 levels through distinct mechanisms.

Authors:  Soon Ji Yoo; Jun R Huh; Israel Muro; Hong Yu; Lijuan Wang; Susan L Wang; R M Renny Feldman; Rollie J Clem; H-Arno J Müller; Bruce A Hay
Journal:  Nat Cell Biol       Date:  2002-06       Impact factor: 28.824

7.  Structural, biochemical, and functional analyses of CED-9 recognition by the proapoptotic proteins EGL-1 and CED-4.

Authors:  Nieng Yan; Lichuan Gu; David Kokel; Jijie Chai; Wenyu Li; Aidong Han; Lin Chen; Ding Xue; Yigong Shi
Journal:  Mol Cell       Date:  2004-09-24       Impact factor: 17.970

8.  Buffy, a Drosophila Bcl-2 protein, has anti-apoptotic and cell cycle inhibitory functions.

Authors:  Leonie Quinn; Michelle Coombe; Kathryn Mills; Tasman Daish; Paul Colussi; Sharad Kumar; Helena Richardson
Journal:  EMBO J       Date:  2003-07-15       Impact factor: 11.598

9.  The Caenorhabditis elegans genes ced-3 and ced-4 act cell autonomously to cause programmed cell death.

Authors:  J Y Yuan; H R Horvitz
Journal:  Dev Biol       Date:  1990-03       Impact factor: 3.582

10.  Debcl, a proapoptotic Bcl-2 homologue, is a component of the Drosophila melanogaster cell death machinery.

Authors:  P A Colussi; L M Quinn; D C Huang; M Coombe; S H Read; H Richardson; S Kumar
Journal:  J Cell Biol       Date:  2000-02-21       Impact factor: 10.539

View more
  28 in total

1.  Mitochondrial pathway of apoptosis is ancestral in metazoans.

Authors:  Cheryl E Bender; Patrick Fitzgerald; Stephen W G Tait; Fabien Llambi; Gavin P McStay; Douglas O Tupper; Jason Pellettieri; Alejandro Sánchez Alvarado; Guy S Salvesen; Douglas R Green
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-13       Impact factor: 11.205

Review 2.  Cell Death Signaling.

Authors:  Douglas R Green; Fabien Llambi
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-12-01       Impact factor: 10.005

Review 3.  Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy.

Authors:  Peter E Czabotar; Guillaume Lessene; Andreas Strasser; Jerry M Adams
Journal:  Nat Rev Mol Cell Biol       Date:  2014-01       Impact factor: 94.444

Review 4.  Mitochondrial regulation of cell death.

Authors:  Stephen W G Tait; Douglas R Green
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-09-01       Impact factor: 10.005

5.  Mammalian apoptosis in a parasitic worm.

Authors:  Saul H Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-14       Impact factor: 11.205

Review 6.  Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases.

Authors:  Andreas Strasser; Suzanne Cory; Jerry M Adams
Journal:  EMBO J       Date:  2011-08-23       Impact factor: 11.598

7.  Molecular characterization of a cytokine-induced apoptosis inhibitor from Schistosoma japonicum.

Authors:  Rong Luo; Chunjing Zhou; Yaojun Shi; Jiangping Zhao; Guofeng Cheng
Journal:  Parasitol Res       Date:  2012-08-30       Impact factor: 2.289

8.  Molecular characterization of SjBIRP, another apoptosis inhibitor, from Schistosoma japonicum.

Authors:  Jinwei Dao; Lihui Zhu; Rong Luo; Chao Hu; Yuqing Wang; Hao Li; Ke Lu; Jinming Liu; Jiaojiao Lin; Guofeng Cheng
Journal:  Parasitol Res       Date:  2014-08-16       Impact factor: 2.289

Review 9.  Current drug targets for helminthic diseases.

Authors:  Ajay Kumar Rana; Shailja Misra-Bhattacharya
Journal:  Parasitol Res       Date:  2013-03-26       Impact factor: 2.289

10.  In vitro screening of compounds against laboratory and field isolates of human hookworm reveals quantitative differences in anthelmintic susceptibility.

Authors:  Rebecca S Treger; Joseph Otchere; Martin F Keil; Josephine E Quagraine; Ganesha Rai; Bryan T Mott; Debbie L Humphries; Michael Wilson; Michael Cappello; Jon J Vermeire
Journal:  Am J Trop Med Hyg       Date:  2013-12-02       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.